Boston Ivy Healthcare Solutions Pvt Ltd. announced that it has raised 638,357 Series C Compulsory Convertible Preference at an issue price of INR 6,788.22 per share for gross proceeds of INR 4,333,307,754.54 led by CDC Group Plc for 1,93,350 shares for INR 1313 million on September 22, 2021. The transaction included participation form Creaegis Principals LLP , Creaegis II Limited for INR 1,650 million from 2,43,068 shares, returning investor Healthquad Fund, a fund managed by returning investor Quadria Capital, Kois Invest, returning investors Mitsui Sumitomo Insurance Venture Capital Co., Ltd for INR 300 million, Ackermans & Van Haaren NV, Rebright Partners, Inc for INR 150 million, and individuals including Arun Venkatchalam and Sunil Kalra. The transaction was co-led by CDC Group Plc, Creaegis Principals LLP , Creaegis II Limited.